0001493152-23-023015.txt : 20230630 0001493152-23-023015.hdr.sgml : 20230630 20230630092505 ACCESSION NUMBER: 0001493152-23-023015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230628 FILED AS OF DATE: 20230630 DATE AS OF CHANGE: 20230630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Trieu Vuong CENTRAL INDEX KEY: 0001587074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 231059788 MAIL ADDRESS: STREET 1: 4003 JIM BOWIE ROAD CITY: AGOURA HILLS STATE: CA ZIP: 91301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncotelic Therapeutics, Inc. CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29397 AGOURA RD. STREET 2: #107 CITY: AGUORA HILLS STATE: CA ZIP: 91301 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 29397 AGOURA RD. STREET 2: #107 CITY: AGUORA HILLS STATE: CA ZIP: 91301 FORMER COMPANY: FORMER CONFORMED NAME: MATEON THERAPEUTICS INC DATE OF NAME CHANGE: 20160613 FORMER COMPANY: FORMER CONFORMED NAME: OXIGENE INC DATE OF NAME CHANGE: 19930628 4 1 ownership.xml X0407 4 2023-06-28 0 0000908259 Oncotelic Therapeutics, Inc. OTLC 0001587074 Trieu Vuong 29397 AGOURA RD SUITE 107 AGOURA HILLS CA 91301 1 1 1 0 CHAIRMAN AND CEO 0 Common Stock 2023-06-29 4 P 0 425000 0.021 A 92044217 D Common Stock 2023-06-28 4 P 0 75000 0.026 A 91619217 D Common Stock 16780384 I By Autotelic, Inc. Common Stock 6872529 I By Spouse On June 28, 2023, Dr. Trieu purchased 75,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.026. Further, on June 29, 2023, Dr. Trieu purchased 425,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.021. /s/ Trieu, Vuong 2023-06-30